GlaxoSmithKline (GSK) has repackaged its newest product, Lucozade Alert, in 250ml cans. The move to the slimline can aims to bring it more in line with consumers' perceptions of mental stimulation drinks. GSK hopes that this new format will improve on the success of last year's product launch, which saw Lucozade Alert achieve sales of £3.5m. The relaunch is supported by a £2m outdoor and digital media advertising campaign.

Price-marked packs are available at 79p.

Topics